GBM5 GBM Model

GBM5 is a Patient-Derived Xenograft (PDX) model for aggressive brain cancer research. It faithfully replicates the disease characteristics of GBM, making it an invaluable tool for studying novel treatments and therapies. PDX models like GBM5 allow researchers to mimic patient-specific tumor environments, providing a realistic platform for preclinical drug testing. This model is crucial for identifying potential drug candidates and evaluating their efficacy before they reach clinical trials. Utilize GBM5 to accelerate the drug discovery process and improve outcomes for brain cancer patients.

Model Details

Cancer Location: Intracranial
Cancer Type: Brain Cancer
Model Name: GBM5
Mouse Strain: Nu/Nu
Treatment Data Available: Chemotherapy (Temozolomide)
WES: Yes
RNAseq: Yes
Methylation: Yes
PDX Treatment: Yes
Patient Treatment History: Yes

GBM5 Survival

Survival of orthotopic intracranial implanted  GBM5  in Nu/Nu mice  (n=5)

Request Additional GBM Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content